Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers

Investigative Radiology

Volumn 40, Issue 4, 2005, Pages 187-194

  Planchamp, Corinne ^a   Montet, Xavier ^a   Frossard, Jean Louis ^a   Quadri, Rafael ^a   Stieger, Bruno ^b   Meier, Peter J ^b   Ivancevic, Marko K ^a   Vallée, Jean Paul ^a   Terrier, François ^a   Pastor, Catherine M ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Gd BOPTA; Liver imaging; Magnetic resonance imaging; Mn DPDP

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARRIER PROTEIN; CONTRAST MEDIUM; GADOBENIC ACID; MULTIDRUG RESISTANCE PROTEIN 2; ORGANIC ANION TRANSPORTING PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BILIARY CIRRHOSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; DRUG ELIMINATION; DRUG TRANSPORT; EXTRACELLULAR SPACE; HISTOPATHOLOGY; LIVER CELL; LIVER CIRRHOSIS; LIVER INJURY; LIVER PERFUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

EID: 20144369493     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rli.0000154587.00638.77     Document Type: Article

References (34)

1. Semelka RC, Helmberger TKG. Contrast agents for MR imaging of the liver. Radiology. 2001;218:27-38.
2. Pastor CM, Planchamp C, Pochon S, et al. Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation. Radiology. 2003;229:119-125.
3. Planchamp C, Gex-Fabry M, Dornier C, et al. Gd-BOPTA transport into rat hepatocytes: pharmacokinetic analysis of magnetic resonance images using a hollow fiber bioreactor. Invest Radiol. 2004;39:506-515.
4. Pascolo L, Petrovic S, Cupelli F, et al. ABC protein transport of MRI contrast agents in canalicular rat liver plasma vesicles and yeast vacuoles. Biochem. Biophys Res Commun. 2001;282:60-66.
5. de Haën C, Lorusso V, Tirone P. Hepatic transport of gadobenate dimeglumine in TR-rats. Acad Radiol. 1996;3:S454-S454.
6. Dumont M, Jacquemin E, D'Hont C, et al. Expression of the liver Na+-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation. J Hepatol. 1997;27:1051-1056.
7. Hyogo H, Tazuma S, Nishioka T, et al. Phospholipid alterations in hepatocyte membranes and transporter protein changes in cholestatic rat model. Dig Dis Sci. 2001;46:2089-2097.
8. Soroka CJ, Lee JM, Azzaroli F, et al. Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology. 2001;33:783-791.
9. Gallez B, Bacic G, Swartz HM. Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP. Magn Reson Med. 1996; 35:14-19.
10. Gallez B, Baudelet C, Adline J, et al. The uptake of Mn-DPDP by hepatocytes is not mediated by the facilitated transport of pyridoxine. Magn Reson Imaging 1996;14:1191-1195.
11. Pastor CM, Wiliams D, Yoneyama T, et al. Competition for tetrahydrobiopterin between phenylalanine hydroxylase and nitric oxide synthase in rat liver. J Biol Chem. 1996;271:24534-24538.
12. Eckhardt U, Schroeder A, Stieger B, et al. Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells. Am J Physiol. 1999;276:G1035-G1042.
13. Reichel C, Gao B, Van Montfoort J, et al. Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver. Gastroenterology. 1999;117:688-695.
14. Cattori V, van Montfoort JE, Stieger B, et al. Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3. Eur J Physiol. 2001;443:188-195.
15. Madon J, Eckhardt U, Gerloff T, et al. Functional expression of the rat liver canalicular isoform of the multidrug resistance-associated protein. FEBS Lett. 1997;406:75-78.
16. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstructions: a new experimental model for cirrhosis in the rat. Br J Exp Pathol. 1984;65:305-311.
17. Alpini G, Roberts S, Kuntz SM, et al. Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. Gastroenterology 1996;110:1636-1643.
18. Alpini G, Ulrich C, Roberts S, et al. Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation. Am J Physiol. 1997;272:G289-G297.
19. LeSage G, Glaser S, Alpini G. Regulation of cholangiocyte proliferation. Liver. 2001;21:73-80.
20. Grazioli L, Morana G, Caudana R, et al. Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings. Invest Radiol. 2001;35:25-34.
21. Manfredi R, Maresca G, Baron RL, et al. Gadobenate dimeglumine (BOPTA) enhanced MR imaging: patterns of enhancement in normal liver and cirrhosis. J Magn Reson Imaging. 1998;8:862-867.
22. Tsuda N, Kato N, Murayama C, et al. Potential for differential diagnosis with gadolinim-ethoxybenzyl-diethyenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumors. Invest Radiol. 2004;39.
23. Sidhu MK, Muller HH, Aggeler J, et al. Manganese dipyridoxal diphosphate-enhanced magnetic resonance imaging in the evaluation of hepatocyte function. Invest Radiol. 1993;28:903-910.
24. Ni Y, Marchal G, Zhang X, et al. The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats. A correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization. Invest Radiol. 1993;28: 520-528.
25. Marti-Bonmati L, Lonjedo E, Poyatos C, et al. MnDPDP enhancement characteristics and differentiation between cirrhotic and noncirrhotic livers. Invest Radiol. 1998;33:717-722.
26. Murakami T, Baron RL, Federle MP, et al. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology. 1996; 198:567-572.
27. Savellano DH, Köstler H, Baus S, et al. Assessment of sequential enhancement patterns of focal nodular hyperplasia and hepatocarcinoma on mangafodipir trisodium enhanced MR imaging. Invest. Radiol. 2004; 39:305-312.
28. Donner MG, Keppler D. Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology. 2001;34:351-359.
29. Paulusma CC, Kothe MJC, Bakker CTM, et al. Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver. Hepatology. 2000;31:684-693.
30. Lee J, Azzaroli F, Wang L, et al. Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology. 2001;121:1473-1484.
31. Tanaka Y, Kobayashi Y, Gabazza EC, et al. Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice. Am J Physiol. 2002;282:G656-G662.
32. Li L, Meier PJ, Ballatori N. Oatp2 mediates bidirectional organic solute transport: a role for intracellular glutathione. Mol Pharmacol. 2000;58: 335-340.
33. Zollner G, Fickert P, Zenz R, et al. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology. 2001;33:633-646.
34. Kullak-Ublick GA, Baretton GB, Oswald M, et al. Expression of the hepatocyte canalicular multidrug resistance protein (MRP2) in primary biliary cirrhosis. Hepatol Res. 2002;23:78-82.